Oncolytics Biotech, Inc. (ONCY)
0.8001
-0.01
(-1.22%)
USD |
NASDAQ |
Jun 10, 16:00
0.8086
+0.01
(+1.06%)
After-Hours: 20:00
Oncolytics Biotech Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2000 | -164.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Replimune Group, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -186.6% |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | 45.29% |
| Anixa Biosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -237.1% |
| Return on Invested Capital | -6.28K% |
| Return on Net Operating Assets | -1.16K% |